Open Menu
Information and Support
About Sickle Cell and Trait
CAMPAIGNING
Blood Donation
Children’s Activities
Clinical Trials and Research
Coronavirus (COVID-19)
Parvo Virus and Sickle Cell
Hackney Engagement Project
Helpline
Heritage Project
Mentoring
Resources
Screening Programme
Self Over Sickle
Support Groups and Local Services
About Us
About the Society
History
Meet the team
SCS 40th Anniversary
Get Involved
Become a Member
Become a fundraiser
Events
Volunteer with us
Work with us
News & Contact
Latest news
Blogs
Contact Us
Help and Advice
Helpline
FAQs
Search
DONATE NOW
Information and Support
About Sickle Cell and Trait
CAMPAIGNING
Blood Donation
Children’s Activities
Clinical Trials and Research
Coronavirus (COVID-19)
Parvo Virus and Sickle Cell
Hackney Engagement Project
Helpline
Heritage Project
Mentoring
Resources
Screening Programme
Self Over Sickle
Support Groups and Local Services
About Us
About the Society
History
Meet the team
SCS 40th Anniversary
Get Involved
Become a Member
Become a fundraiser
Events
Volunteer with us
Work with us
News & Contact
Latest news
Blogs
Contact Us
Help and Advice
Helpline
FAQs
Search
DONATE NOW
FB Crizanlizumab Update
Home
»
News
»
Crizanlizumab statement. January 2024
»
FB Crizanlizumab Update
FB Crizanlizumab Update
Share Post:
Crizanlizumab statement. January 2024
Categories
About Sickle Cell Blog
APPG
Breaking Down Barriers
Children’s Activities
Clinical Trials
Events
Fundraising
Give Blood, Spread Love, England
Iron Overload
Mentoring Blog
News
Our Journey Our Story
Paid Vacancy
Photos
Real Lives Blog
Screening Programme
SCS40
SCS40 Events
Self Over Sickle
Service Review
South London Link
Uncategorised
Volunteer Role
Work with Us
Latest News
Vacancy : Chair of the Board of Trustees
16th January 2025
Paid Vacancy: Lead Mentor – Sickle Cell Children & Young Person’s Peer Mentoring Programme (London Region)
13th January 2025
Exploring New Treatment Options for Severe Sickle Cell Disorder : The Redress Study
4th November 2024
© 2021 Sickle Cell Society. All rights reserved.
Site developed by
Premier Choice Internet
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok
DONATE NOW
